Northpond Ventures

Northpond Ventures Northpond Ventures is a life sciences and technology-focused VC with 74 portfolio companies, 5 IPOs, and 12 acquisitions including 908 Devices, Syapse, and Sherlock Biosciences. The fund has maintained consistent deployment with 6 investments in 2024 and 4 in early 2025, showing sustained activity in a market where many life sciences investors pulled back. The synthetic biology angle is particularly strong: Northpond led a $21M financing alongside Novalis LifeSciences in synth